Navigation Links
Facet Solutions' AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing

LOGAN, Utah, Oct. 22 /PRNewswire/ -- Facet Solutions, Inc. announced today that testing conducted by Professor Vijay Goel, PhD., from the Department of Bioengineering at the University of Toledo, demonstrated that the Anatomic Facet Replacement System (AFRS(TM)) has shown biomechanical advantages when compared to dynamic stabilization devices. The objective of the testing was to compare the range of motion, pedicle screw stresses, and spinal stability of facet joint replacement versus dynamic stabilization devices.

An experimentally validated computer model of the spine implanted with the AFRS(TM) demonstrated reduced stresses in the pedicle screws supporting the implant. In addition, the results showed improved motion and structural support to the spine.

"Three inherent characteristics of the AFRS(TM) are thought to contribute to these positive results," stated Professor Goel. "These characteristics are: the anatomic implant design, the unconstrained range of motion, and the replacement of diseased bone with a cobalt chrome implant. Additional testing will be conducted to determine the impact that the AFRS(TM) will have on disc pressures when implanted in the spine."

When treating patients with low back pain, one of the most important concerns for a spine surgeon is how to stabilize the spine after performing a spinal decompression (removal of bone around inflamed nerve roots). In the past, the only option available was a spinal fusion. However, a fusion eliminates motion and may cause the joints adjacent to the fusion to degenerate more quickly. These concerns lead to the development of motion preservation devices like dynamic stabilization and facet joint replacement. Dynamic stabilization is an adjunct to fusion and typically utilizes preloaded rods and screws to provide controlled motion. By contrast, facet joint replacement allows for unconstrained motion and mimics the natural kinematics, balance, and stability in the spine joints; similar to hip and knee joint replacement devices.

Recent studies have shown that the constrained nature of dynamic stabilization increases screw stresses. This increase may have contributed to the higher rates of screw loosening and resulted in limited range of motion. The objective of the biomechanical testing was to determine if the use of an unconstrained implant could potentially eliminate the disadvantages of dynamic stabilization.

Eric Bannon, VP of Clinical and Regulatory Affairs, stated, "The AFRS(TM) was designed with the objective of overcoming the inherent weaknesses of spinal fusion and dynamic stabilization. As a company, we felt it was important to invest in this stringent testing procedure to ensure that the AFRS(TM) would result in positive clinical outcomes. We were pleased to find that our product outperformed spinal fusion and dynamic stabilization in several key areas. The company looks forward to expanding this biomechanical outcome data with results from an ongoing FDA approved IDE Study."

The summary findings from this biomechanical testing will be presented at the Science of Facet Joint Repair and Total Posterior Arthroplasty Symposium which will be held in Austin, Texas at the Omni Hotel on Monday, October 22, 2007 at 6:30 PM.

* Note: AFRS(TM) is an investigational device in the United States. It is

limited by United States (U.S.) Federal Law for investigational use


About Facet Solutions

Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.

SOURCE Facet Solutions
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
2. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:11/26/2015)... -- Research and Markets ( ) has announced the ... to 2019 - Rise in Cardiac Disorders and Growing Awareness ... their offering. Boston scientific ... scientific and others. --> The market is ... Boston scientific and others. ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... of the "Self Administration of High Viscosity ... ) has announced the addition of ... report to their offering. --> ... the addition of the "Self Administration of ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... 26, 2015 , ... Indosoft Inc., developer and distributor of the world-class Asterisk ... system efficiency and reliability. , The new Q-Suite 6 platform is based on the ... locking itself into a specific piece of software for many key components of the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, ... new Wimbledon Athletics Facebook page to educate the public, parents and ... abnormalities. About 2,000 people under the age of 25 die from sudden cardiac ...
(Date:11/25/2015)... ... ... Beddit® has launched a new Android app for use with ... more intuitive SleepScore™ that rates sleep quality on a 100-point scale and makes it ... a proprietary algorithm. Beddit analyzes the data to provide an easy to understand scientific ...
Breaking Medicine News(10 mins):